These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 316435)

  • 21. Platelet adhesion to collagen in subtypes of type I von Willebrand's disease is dependent on platelet von Willebrand factor.
    d'Alessio P; Zwaginga JJ; de Boer HC; Federici AB; Rodeghiero F; Castaman G; Mariani G; Mannucci PM; de Groot PG; Sixma JJ
    Thromb Haemost; 1990 Oct; 64(2):227-31. PubMed ID: 2125373
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy of intensive plasma exchange in acquired von Willebrand's disease.
    Silberstein LE; Abrahm J; Shattil SJ
    Transfusion; 1987; 27(3):234-7. PubMed ID: 3109084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-induced von Willebrand's disease: a newly defined inhibitor syndrome.
    Handin RI; Martin V; Moloney WC
    Blood; 1976 Sep; 48(3):393-405. PubMed ID: 1085186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand's disease.
    Weiss HJ; Pietu G; Rabinowitz R; Girma JP; Rogers J; Meyer D
    J Lab Clin Med; 1983 Mar; 101(3):411-25. PubMed ID: 6186757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type IIB von Willebrand's disease: unusual response to cryoprecipitate infusion.
    Weinger RS; Cimo PL; Moake JL; Olson JD; Heller MS
    Ann Intern Med; 1981 Jan; 94(1):47-50. PubMed ID: 6778284
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spectrum of von Willebrand's Disease: a study of 100 cases. Italian Working Group.
    Br J Haematol; 1977 Jan; 35(1):101-12. PubMed ID: 300628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies of the human factor VIII/von Willebrand factor protein. III. Qualitative defects in von Willebrand's disease.
    Gralnick HR; Coller BS; Sultan Y
    J Clin Invest; 1975 Oct; 56(4):814-27. PubMed ID: 1080491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the prolonged bleeding time in von Willebrand's disease.
    Mannucci PM; Pareti FI; Holmberg L; Nilsson IM; Ruggeri ZM
    J Lab Clin Med; 1976 Oct; 88(4):662-71. PubMed ID: 787458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heightened interaction between platelets and factor VIII/von Willebrand factor in a new subtype of von Willebrand's disease.
    Ruggeri ZM; Pareti FI; Mannucci PM; Ciavarella N; Zimmerman TS
    N Engl J Med; 1980 May; 302(19):1047-51. PubMed ID: 6767976
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two cases of atypical von Willebrand's disease with inhibitory effect on von Willebrand factor (author's transl)].
    Fukui H; Okuda T; Takase T; Mikami S; Yoshioka A; Fujimura Y; Yoshioka K
    Nihon Ketsueki Gakkai Zasshi; 1978 Oct; 41(5):897-907. PubMed ID: 310619
    [No Abstract]   [Full Text] [Related]  

  • 32. The spectrum of von Willebrand's disease revisited.
    Bowie EJ; Fass DN; Olson JD; Owen CA
    Mayo Clin Proc; 1976 Jan; 51(1):35-41. PubMed ID: 765637
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acquired von Willebrand's disease. Evidence for a quantitative and qualitative factor VIII disorder.
    Joist JH; Cowan JF; Zimmerman TS
    N Engl J Med; 1978 May; 298(18):988-91. PubMed ID: 306064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective absence of large forms of factor VIII/von Willebrand factor in acquired von Willebrand's syndrome. Response to transfusion.
    Meyer D; Frommel D; Larrieu MJ; Zimmerman TS
    Blood; 1979 Sep; 54(3):600-6. PubMed ID: 313821
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of von Willebrand's disease.
    Mannucci PM
    J Intern Med Suppl; 1997; 740():129-32. PubMed ID: 9350194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acquired von Willebrand's disease in association with Wilm's tumor: regression following treatment.
    Scott JP; Montgomery RR; Tubergen DG; Hays T
    Blood; 1981 Oct; 58(4):665-9. PubMed ID: 6268230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody nature of circulating inhibitor of plasma von Willebrand factor.
    Stratton RD; Wagner RH; Webster WP; Brinkhous KM
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4167-71. PubMed ID: 812091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acquired von Willebrand's disease caused by a monoclonal antibody.
    Zettervall O; Nilsson IM
    Acta Med Scand; 1978; 204(6):521-8. PubMed ID: 310632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibody-induced von Willebrand syndrome: inhibition of VIII VWF and VIII AGN with sparing of VIII AHF by the autoantibody.
    Gazengel C; Prieur AM; Jacques C; Buriot D; Nedellec J; Josso F
    Am J Hematol; 1978; 5(4):355-63. PubMed ID: 313704
    [No Abstract]   [Full Text] [Related]  

  • 40. Platelet membrane glycoproteins implicated in ristocetin-induced aggregation. Studies of the proteins on platelets from patients with Bernard-Soulier syndrome and von Willebrand's disease.
    Jenkins CS; Phillips DR; Clemetson KJ; Meyer D; Larrieu MJ; Lüscher EF
    J Clin Invest; 1976 Jan; 57(1):112-24. PubMed ID: 1081991
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.